Our Terms of Service and Privacy Policy have changed.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.
|
|
| 4.72 Delayed Data As of Sep 23 |  -0.09 / -1.87%Today’s Change | 4.14 Today|||52-Week Range 7.74 | -21.72% Year-to-Date |
| Spectrum (SPPI) Down, Qapzola Fails to Impress FDA Panel Sep 15 / Zacks.com - Paid Partner Content | The Zacks Analyst Blog Highlights: Spectrum Pharmaceuticals, Amgen, AbbVie and Vertex... Sep 13 / Zacks.com - Paid Partner Content |
| FDA AdCom Votes on Pfizer and Spectrum Drugs - What Next? Sep 15 / Zacks.com - Paid Partner Content | 3 Drug Stocks That Could Benefit from Key FDA Events in Sep 2016 Sep 12 / Zacks.com - Paid Partner Content |
| Biotech Stock Roundup: Horizon-Raptor Acquisition Deal, Geron Down on Pipeline News Sep 14 / Zacks.com - Paid Partner Content |
